All News Top News Mar 22, 2019 Teva Announces Launch of a Generic Version of EXJADE® (deferasirox) Tablets For Oral Suspension in the United States Learn More Share Top News Mar 1, 2019 Teva Announces Launch of an Authorized Generic of Flector® Patch (diclofenac epolamine topical patch) in the United States Learn More Share Top News Feb 19, 2019 Teva Finalizes Settlement with Federal Trade Commission to Resolve All Outstanding Litigation between the Parties Learn More Share Top News Feb 13, 2019 Teva Reports Fourth Quarter and Full Year 2018 Financial Results Learn More Share Top News Feb 6, 2019 Teva Announces U.S. Launch of a Generic Version of Sabril® (Vigabatrin) Learn More Share
Top News Mar 22, 2019 Teva Announces Launch of a Generic Version of EXJADE® (deferasirox) Tablets For Oral Suspension in the United States Learn More
Top News Mar 1, 2019 Teva Announces Launch of an Authorized Generic of Flector® Patch (diclofenac epolamine topical patch) in the United States Learn More
Top News Feb 19, 2019 Teva Finalizes Settlement with Federal Trade Commission to Resolve All Outstanding Litigation between the Parties Learn More
Top News Feb 6, 2019 Teva Announces U.S. Launch of a Generic Version of Sabril® (Vigabatrin) Learn More